Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Lamotrigine Award

Awarded
SPE2D2-25-D-0013Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract modification exercises Option Year 1 for the supply of Lamotrigine ER Tablets under award SPE2D2-25-D-0013, with a total estimated contract value of $15,978,181.35 across a five-year period including a base year and four option years. The contract is awarded to AvKare, LLC, a small business with multiple socioeconomic designations including HUBZone, SDVOSB, WOSB, EDWOSB, and 8(a), operating under NAICS code 325412 for pharmaceutical preparation manufacturing. The scope of work involves the provision of six strength formulations of Lamotrigine ER 24 mg tablets in 30-count bottles, with identical quantities and unit prices for each option year, totaling 3,216 bottles for the 25mg strength, 2,482 for the 50mg, 11,904 for the 100mg, 15,775 for the 200mg, 3,734 for the 250mg, and 7,510 for the 300mg. Delivery is FOB destination, with performance and manufacturing taking place at Anneal, 50 Horseblock Rd, Brookhaven, NY 11719, and invoices must be submitted to the DLA Pharmaceutical Prime Vendor or VA Pharmaceutical Prime Vendor per Block 18a. The contract is fixed-price in nature, governed by standard FAR and DFARS clauses, including mandatory compliance with ethics codes, whistleblower protections, equal opportunity requirements, combating trafficking in persons, electronic invoicing under DFARS 252.232-7003, and accelerated payments to small business subcontractors. Cybersecurity obligations are enforced through DFARS 252.204-7012 for safeguarding covered defense information, with additional prohibitions on the use of Kaspersky Lab products, ByteDance applications, and unmanned aircraft systems from covered foreign entities. The contractor is required to report executive compensation and first-tier subcontract awards via FFATA, maintain a small business subcontracting plan, and comply with all applicable labor standards including paid sick leave and minimum wage requirements. The point of contact for administration is Nancy Fernandez of DLA Troop Support in Philadelphia, PA, and the contract does not designate a COR or COTR. No explicit

General Info

Exercise of Option Year 1 for Lamotrigine ER Tablets, $2.88M, AvKARE, LLC, FOB Destination, May 2026–2027.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Brookhaven, NY, 11719, USA

Set-Aside

NONE

Awardee

AVKARE LLC

Award Issued Date

Documents

2

SPE2D2-25-D-0013 Award - AvKARE, LLC

PDF, High priority: read this firstaward
High

SPE2D2-25-D-0013 Mod P00001 - Lamotrigine

PDF, High priority: read this firstmodification
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA

Full Description

Show more

Modification to exercise Option Year 1 for Lamotrigine ER Tablets is attached. 

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
HYDROXYPROPYL METHYLCE
Solicitation # SPE2DP-27-T-0185
Solicitation SPE2DP-27-T-0185 is a Small Business Set-Aside request for the procurement of Ocucoat Viscoelastic 1ML, a 2% hydroxypropyl methylcellulose ophthalmic solution (NSN 6505016331037). This FDA-regulated medical device is designed for high-volume, small-incision cataract surgery and lens inserter lubrication. The requirement consists of 5 boxes, with a delivery timeline of 79 days after receipt of order and an original required delivery date of October 27, 2026. Delivery is FOB Destination, with the final destination located at the USA Med Mat Ctr EUR in Kaiserslautern, Germany. The contract mandates strict quality and shelf-life compliance, requiring a non-extendable shelf life of 24 months per RS016. Packaging must be commercial and sealed to prevent damage, adhering to MIL-STD-2073-1E and DLA packaging requirements. Marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment. The procurement is subject to various DFARS and FAR clauses, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
EMOLLIENT LOTION
Solicitation # SPE2DP-27-T-0188
Solicitation SPE2DP-27-T-0188 is a procurement for emollient lotion under NAICS code 325412, managed by the Defense Logistics Agency. The requirement consists of multiple line items, including 500 bottles for CLIN 0001 and 12 bottles for CLIN 0002, with an additional 250 bottles for CLIN 0003. The product must be a non-sterile, homogeneous oil-in-water or water-in-oil emulsion with a pH range between 5.0 and 8.1 and a viscosity of 10,000 to 20,000 CPS. Each unit consists of a 240 ML (8 FL OZ) bottle equipped with a dispenser cap. The lotion must contain water, a suitable oil, an emulsifier, and a preservative, and it must be stored at controlled room temperature. Delivery is required within 20 days after the order, with specific required delivery dates ranging from June 17, 2026, to July 20, 2026. Shipments are designated as FOB Destination to various locations, including the USS George Washington, USS Iwo Jima, and the USNS Mercy. Packaging must comply with MIL-STD-129 and Medical Marking Standard No. 1, with non-hazardous materials following ASTM D3951 and hazardous materials adhering to TQ requirement IP025 and FED-STD-313. Palletization must follow DLA requirement RP001. The contract incorporates various FAR and DFARS clauses, including the Buy American Act, Wide Area Workflow for electronic payments, and destination inspection requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS